About Jacqueline Hess
Jacqueline Hess is a director at Immunophotonics.
Experience
This experience comes from Jacqueline Hess's profile and from SEC filings. For roles taken from filings, the years are when the filings name Jacqueline Hess in the role, so the role may have started earlier or lasted longer.
HG
H+H Strategic Consulting GmbH Current
Managing Partner
2026 – Present
Immunophotonics, Inc. Current
Non Executive Director (2024 – Present)
Director
2024 – Present · St. Louis, MO
Develops immune-stimulating treatments for people with solid-tumor cancers.
CS
Companion Spine Current
Non Executive Director
2024 – Present
TB
the Boardroom Current
Chair (Switzerland)
2024 – Present
VA
Vontobel Swiss Financial Advisers AG
Vice Chair Board of Directors (2023 – 2026)
Chief Executive Officer at Vontobel Swiss Wealth Advisors AG (2021 – 2022)
2021 – 2026
DE
Deloitte
Partner
2005 – 2021
PA
PricewaterhouseCoopers AG
Director
1994 – 2005
Key Colleagues at Startups
The people Jacqueline Hess works with at each company, as listed on that company's latest Form D.
Immunophotonics, Inc. · Form D, Sep 4, 2026
MZ
Miguel Zubizarreta
Director
RL
Richard Levenson
Director
Luciano Alleruzzo
Co-founder & Director
Jonathan Knowles
Chairman
Robert Arch
CEO & President
Wei Chen
Co-founder, Co-inventor & Director
Alexander Hurst
Chief Corporate Officer & General Counsel